发明名称 |
Compositions for pulmonary delivery of long-acting β<sub>2 </sub>adrenergic receptor agonists and associated methods and systems |
摘要 |
Compositions, methods and systems are provided for pulmonary delivery of long-acting muscarinic antagonists and long-acting β2 adrenergic receptor agonists via a metered dose inhaler. In particular embodiments, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium. |
申请公布号 |
US8808713(B2) |
申请公布日期 |
2014.08.19 |
申请号 |
US201012790605 |
申请日期 |
2010.05.28 |
申请人 |
Pearl Thereapeutics, Inc. |
发明人 |
Vehring Reinhard;Hartman Michael Steven;Smith Adrian Edward;Joshi Vidya B.;Dwivedi Sarvajna Kumar |
分类号 |
A61K9/12;A61K9/14 |
主分类号 |
A61K9/12 |
代理机构 |
Seed IP Law Group PLLC |
代理人 |
Seed IP Law Group PLLC |
主权项 |
1. A pharmaceutical composition deliverable from a metered dose inhaler, comprising:
a suspension medium substantially free of cosolvents and solubilizing agents and comprising a pharmaceutically acceptable propellant; a plurality of respirable active agent particles (AAP) comprising a pharmaceutically acceptable salt, ester, isomer, or solvate of formoterol; and a plurality of respirable suspending particles (RSP) formed separately from the plurality of AAP, wherein the RSP comprise a dry particulate phospholipid material that is substantially insoluble in the suspension medium, and wherein the RSP are present in the suspension medium at a concentration of up to about 30 mg/mL and at a weight ratio of total mass of RSP to total mass of AAP that ranges from above 1:1 up to 200:1. |
地址 |
Redwood City CA US |